MCC is a highly aggressive primary cutaneous neuroendocrine carcinoma with epithelial and endocrine features. Its origin is disputed, with epidermal Merkel cell precursors, pre-B cells, pro-B cells, or dermal fibroblasts all suggested.[7]Gauci ML, Aristei C, Becker JC, et al; the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - update 2022. Eur J Cancer. 2022 Aug:171:203-31.
https://www.ejcancer.com/article/S0959-8049(22)00253-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/35732101?tool=bestpractice.com
MCC tumorigenesis is attributed to two main etiologies with distinct molecular pathogenetic pathways: integration of MCPyV into the host genome, or exposure to UV radiation.[7]Gauci ML, Aristei C, Becker JC, et al; the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - update 2022. Eur J Cancer. 2022 Aug:171:203-31.
https://www.ejcancer.com/article/S0959-8049(22)00253-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/35732101?tool=bestpractice.com
[19]Lugowska I, Becker JC, Ascierto PA, et al; ESMO Guidelines Committee. Merkel-cell carcinoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open. 2024 May;9(5):102977.
https://www.esmoopen.com/article/S2059-7029(24)00745-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/38796285?tool=bestpractice.com
MCPyV is a ubiquitous polyomavirus with 60% to 80% seropositivity in the US adult population.[20]Pastrana DV, Tolstov YL, Becker JC, et al. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog. 2009 Sep;5(9):e1000578.
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1000578
http://www.ncbi.nlm.nih.gov/pubmed/19750217?tool=bestpractice.com
MCPyV infection is typically asymptomatic.[20]Pastrana DV, Tolstov YL, Becker JC, et al. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog. 2009 Sep;5(9):e1000578.
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1000578
http://www.ncbi.nlm.nih.gov/pubmed/19750217?tool=bestpractice.com
While viral infection is common, oncogenic transformation by MCPyV is rare as it requires integration into the host genome.[20]Pastrana DV, Tolstov YL, Becker JC, et al. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog. 2009 Sep;5(9):e1000578.
https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1000578
http://www.ncbi.nlm.nih.gov/pubmed/19750217?tool=bestpractice.com
[21]Chang Y, Moore PS. Merkel cell carcinoma: a virus-induced human cancer. Annu Rev Pathol. 2012;7:123-44.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732449
http://www.ncbi.nlm.nih.gov/pubmed/21942528?tool=bestpractice.com
MCPyV-positive MCCs have a low tumor mutational burden but harbor clonal integration of the virus.[7]Gauci ML, Aristei C, Becker JC, et al; the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - update 2022. Eur J Cancer. 2022 Aug:171:203-31.
https://www.ejcancer.com/article/S0959-8049(22)00253-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/35732101?tool=bestpractice.com
UV-associated MCCs, which usually occur on sun-exposed parts of the body, are characterized by a high tumor mutational burden, with enrichment of the UV-DNA damage signature seen in MCPyV-negative MCC tumors.[7]Gauci ML, Aristei C, Becker JC, et al; the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - update 2022. Eur J Cancer. 2022 Aug:171:203-31.
https://www.ejcancer.com/article/S0959-8049(22)00253-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/35732101?tool=bestpractice.com
[22]Harms PW, Vats P, Verhaegen ME, et al. The distinctive mutational spectra of polyomavirus-negative Merkel cell carcinoma. Cancer Res. 2015 Sep 15;75(18):3720-7.
https://aacrjournals.org/cancerres/article/75/18/3720/606509/The-Distinctive-Mutational-Spectra-of-Polyomavirus
http://www.ncbi.nlm.nih.gov/pubmed/26238782?tool=bestpractice.com
[23]Wong SQ, Waldeck K, Vergara IA, et al. UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas. Cancer Res. 2015 Dec 15;75(24):5228-34.
https://aacrjournals.org/cancerres/article/75/24/5228/606653/UV-Associated-Mutations-Underlie-the-Etiology-of
http://www.ncbi.nlm.nih.gov/pubmed/26627015?tool=bestpractice.com
[24]Goh G, Walradt T, Markarov V, et al. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget. 2016 Jan 19;7(3):3403-15.
https://www.oncotarget.com/article/6494/text
http://www.ncbi.nlm.nih.gov/pubmed/26655088?tool=bestpractice.com
[25]Schadendorf D, Lebbé C, Zur Hausen A, et al. Merkel cell carcinoma: epidemiology, prognosis, therapy and unmet medical needs. Eur J Cancer. 2017 Jan;71:53-69.
https://www.ejcancer.com/article/S0959-8049(16)32526-6/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/27984768?tool=bestpractice.com
[26]Starrett GJ, Thakuria M, Chen T, et al. Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma. Genome Med. 2020 Mar 18;12(1):30.
https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-020-00727-4
http://www.ncbi.nlm.nih.gov/pubmed/32188490?tool=bestpractice.com
Retinoblastoma protein and p53 are among the most significantly mutated genes.[7]Gauci ML, Aristei C, Becker JC, et al; the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - update 2022. Eur J Cancer. 2022 Aug:171:203-31.
https://www.ejcancer.com/article/S0959-8049(22)00253-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/35732101?tool=bestpractice.com